Inventor · disambiguated record
Elise Rioux
Also filed as: RIOUX ELISE
11 granted patents·12 pending applications·23 citations·filing 2004–2025
89Inventor score
Files withMILESTONE PHARMACEUTICALS INC18ATTARDO GIORGIO2GEMIN X PHARMACEUTICALS CANADA2GEMIN X BIOTECHNOLOGIES1
Top patents by PatentIndex Score
23 records- 0192US2024366552A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0290US10010523B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·4 cites·1 claims
- 0390US2024115543A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0488US2023255923A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0586US10010522B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·2 cites·1 claims
- 0685US10010524B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·2 cites·4 claims
- 0784US9737503B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2016·Granted Aug 22, 2017·2 cites·4 claims
- 0884US9463179B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2015·Granted Oct 11, 2016·2 cites·12 claims
- 0982US9227918B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2014·Granted Jan 5, 2016·2 cites·7 claims
- 1082US2022142963A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1182US2025195462A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1281US2021315855A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1379US2021059972A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1476US7709477B2Methods for treating cancerGEMIN X PHARMACEUTICALS CANADA·Filed 2008·Granted May 4, 2010·2 cites·8 claims
- 1575US2020230097A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1674US2019380993A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1772US7425553B2Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseasesGEMIN X PHARMACEUTICALS CANADA·Filed 2004·Granted Sep 16, 2008·5 cites·4 claims
- 1872US2019142781A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1971US2018280339A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2068US2010190852A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2150US8420638B2Triheterocyclic compounds and compositions thereofATTARDO GIORGIO·Filed 2011·Granted Apr 16, 2013·0 cites·3 claims
- 2248US7230139B2Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agentsGEMIN X BIOTECHNOLOGIES·Filed 2004·Granted Jun 12, 2007·2 cites·25 claims
- 2336US8420693B2Dipyrrole compounds, compositions, and methods for treating cancer or viral diseasesATTARDO GIORGIO·Filed 2005·Granted Apr 16, 2013·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →